• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BPIFB1(LPLUNC1)通过抑制 VTN 表达抑制鼻咽癌的放射抵抗性。

BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression.

机构信息

The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, Hunan, China.

The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China.

出版信息

Cell Death Dis. 2018 Apr 1;9(4):432. doi: 10.1038/s41419-018-0409-0.

DOI:10.1038/s41419-018-0409-0
PMID:29568064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5864881/
Abstract

Bactericidal/permeability-increasing-fold-containing family B member 1 (BPIFB1, previously named LPLUNC1) is highly expressed in the nasopharynx and significantly downregulated in nasopharyngeal carcinoma (NPC). Low expression is also associated with poor prognosis in patients with NPC. Radiotherapy is a routine treatment for NPC; however, radioresistance is a major cause of treatment failure. Thus, we aimed to investigate the role of BPIFB1 in the radioresponse of NPC. Colony formation and cell survival results showed that BPIFB1 sensitized NPC cells to ionizing radiation. VTN, a previously identified BPIFB1-binding protein, was shown to induce cell proliferation and survival, G2/M phase arrest, DNA repair, activation of the ATM-Chk2 and ATR-Chk1 pathways, and anti-apoptotic effects after exposure to radiation, facilitating NPC cell radioresistance. However, BPIFB1 inhibited this VTN-mediated radioresistance, ultimately improving NPC radiosensitivity. In conclusion, this study is the first to demonstrate the functions of BPIFB1 and VTN in the NPC radioresponse. Our findings indicated that promoting BPIFB1 expression and targeting VTN might represent new therapeutic strategies for NPC.

摘要

杀菌/通透性增加蛋白家族 B 成员 1(BPIFB1,以前称为 LPLUNC1)在鼻咽部高度表达,在鼻咽癌(NPC)中显著下调。低表达与 NPC 患者的预后不良相关。放射治疗是 NPC 的常规治疗方法;然而,放射抵抗是治疗失败的主要原因。因此,我们旨在研究 BPIFB1 在 NPC 放射反应中的作用。集落形成和细胞存活结果表明,BPIFB1 使 NPC 细胞对电离辐射敏感。VTN 是先前鉴定的 BPIFB1 结合蛋白,在暴露于辐射后显示出诱导细胞增殖和存活、G2/M 期阻滞、DNA 修复、激活 ATM-Chk2 和 ATR-Chk1 途径以及抗细胞凋亡作用,从而促进 NPC 细胞放射抵抗。然而,BPIFB1 抑制了 VTN 介导的放射抵抗,最终提高了 NPC 的放射敏感性。总之,这项研究首次证明了 BPIFB1 和 VTN 在 NPC 放射反应中的作用。我们的研究结果表明,促进 BPIFB1 表达和靶向 VTN 可能代表 NPC 的新治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/e054462b2c1f/41419_2018_409_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/4d907519b2d3/41419_2018_409_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/8d234367dbf9/41419_2018_409_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/b393d973d631/41419_2018_409_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/b1497348b1d3/41419_2018_409_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/c70fedf56c62/41419_2018_409_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/e054462b2c1f/41419_2018_409_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/4d907519b2d3/41419_2018_409_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/8d234367dbf9/41419_2018_409_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/b393d973d631/41419_2018_409_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/b1497348b1d3/41419_2018_409_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/c70fedf56c62/41419_2018_409_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec2e/5864881/e054462b2c1f/41419_2018_409_Fig6_HTML.jpg

相似文献

1
BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression.BPIFB1(LPLUNC1)通过抑制 VTN 表达抑制鼻咽癌的放射抵抗性。
Cell Death Dis. 2018 Apr 1;9(4):432. doi: 10.1038/s41419-018-0409-0.
2
BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.BPIFB1(LPLUNC1)通过与 VTN 和 VIM 相互作用抑制鼻咽癌细胞的迁移和侵袭。
Br J Cancer. 2018 Jan;118(2):233-247. doi: 10.1038/bjc.2017.385. Epub 2017 Nov 9.
3
SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.SALL4 通过 ATM/Chk2/p53 通路诱导鼻咽癌的放射抵抗。
Cancer Med. 2019 Apr;8(4):1779-1792. doi: 10.1002/cam4.2056. Epub 2019 Mar 24.
4
SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.SHP-1过表达通过增强双链断裂修复、增加S期阻滞和减少细胞凋亡来提高鼻咽癌细胞的放射抗性。
Oncol Rep. 2015 Jun;33(6):2999-3005. doi: 10.3892/or.2015.3939. Epub 2015 Apr 28.
5
BPIFB1 inhibits vasculogenic mimicry via downregulation of GLUT1-mediated H3K27 acetylation in nasopharyngeal carcinoma.BPIFB1 通过下调 GLUT1 介导的 H3K27 乙酰化抑制鼻咽癌中的血管生成拟态。
Oncogene. 2022 Jan;41(2):233-245. doi: 10.1038/s41388-021-02079-8. Epub 2021 Nov 1.
6
Radiotherapy induces cell cycle arrest and cell apoptosis in nasopharyngeal carcinoma via the ATM and Smad pathways.放射疗法通过 ATM 和 Smad 通路诱导鼻咽癌细胞周期停滞和细胞凋亡。
Cancer Biol Ther. 2017 Sep 2;18(9):681-693. doi: 10.1080/15384047.2017.1360442.
7
In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.ATM/ATR信号通路对鼻咽癌细胞增殖、凋亡及放射敏感性的体内和体外作用
Cancer Biother Radiopharm. 2017 Aug;32(6):193-203. doi: 10.1089/cbr.2017.2212.
8
Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.β-连环蛋白的过表达降低了人鼻咽癌CNE-2细胞的放射敏感性。
Cell Physiol Biochem. 2018;50(5):1929-1944. doi: 10.1159/000494873. Epub 2018 Nov 5.
9
LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.LPLUNC1 通过下调 MAP 激酶和细胞周期蛋白 D1/E2F 通路抑制鼻咽癌细胞生长。
PLoS One. 2013 May 1;8(5):e62869. doi: 10.1371/journal.pone.0062869. Print 2013.
10
EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.EBV 编码的 miRNA BART8-3p 通过调节 ATM/ATR 信号通路促进鼻咽癌的放射抵抗。
Biosci Rep. 2019 Sep 13;39(9). doi: 10.1042/BSR20190415. Print 2019 Sep 30.

引用本文的文献

1
Cardamonin anticancer effects through the modulation of the tumor immune microenvironment in triple-negative breast cancer cells.小豆蔻明通过调节三阴性乳腺癌细胞中的肿瘤免疫微环境发挥抗癌作用。
Am J Cancer Res. 2024 Dec 15;14(12):5644-5664. doi: 10.62347/ANXS3815. eCollection 2024.
2
TMT-based proteomic analysis of radiation lung injury in rats.基于TMT的大鼠放射性肺损伤蛋白质组学分析
Clin Proteomics. 2024 Dec 19;21(1):67. doi: 10.1186/s12014-024-09518-0.
3
CLCA1 and BPIFB1 are potential novel biomarkers for asthma: an iTRAQ analysis.

本文引用的文献

1
Long non-coding RNA PVT1 predicts poor prognosis and induces radioresistance by regulating DNA repair and cell apoptosis in nasopharyngeal carcinoma.长链非编码 RNA PVT1 通过调节鼻咽癌中的 DNA 修复和细胞凋亡来预测不良预后并诱导放射抵抗。
Cell Death Dis. 2018 Feb 14;9(2):235. doi: 10.1038/s41419-018-0265-y.
2
Trend analysis of cancer incidence and mortality in China.中国癌症发病率和死亡率的趋势分析。
Sci China Life Sci. 2017 Nov;60(11):1271-1275. doi: 10.1007/s11427-017-9172-6. Epub 2017 Oct 16.
3
BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
CLCA1和BPIFB1是哮喘潜在的新型生物标志物:一项iTRAQ分析。
J Thorac Dis. 2024 Oct 31;16(10):6955-6968. doi: 10.21037/jtd-24-1366. Epub 2024 Oct 28.
4
Integrative multi-omics analysis unveils the connection between transcriptomic characteristics associated with mitochondria and the tumor immune microenvironment in lower-grade gliomas.整合多组学分析揭示了与线粒体相关的转录组特征与低级别脑胶质瘤肿瘤免疫微环境之间的联系。
Sci Rep. 2024 Oct 10;14(1):23675. doi: 10.1038/s41598-024-74281-z.
5
PLGA- Polysaccharide Nanovaccines Exert Therapeutic Effect in Colorectal Cancer.PLGA-多糖纳米疫苗在结直肠癌中发挥治疗作用。
Int J Nanomedicine. 2024 Sep 12;19:9437-9458. doi: 10.2147/IJN.S479334. eCollection 2024.
6
BPIFB1, Serving as a Downstream Effector of EBV-miR-BART4, Blocks Immune Escape of Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression.BPIFB1作为EBV-miR-BART4的下游效应因子,通过抑制PD-L1表达来阻断鼻咽癌的免疫逃逸。
Biochem Genet. 2025 Feb;63(1):540-556. doi: 10.1007/s10528-024-10719-3. Epub 2024 Mar 11.
7
BPIFB1 promotes metastasis of hormone receptor-positive breast cancer via inducing macrophage M2-like polarization.BPIFB1 通过诱导巨噬细胞 M2 样极化促进激素受体阳性乳腺癌的转移。
Cancer Sci. 2023 Nov;114(11):4157-4171. doi: 10.1111/cas.15957. Epub 2023 Sep 13.
8
The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker.细胞衰老调控因子 p16 是一种很有前途的癌症预后和免疫检查点抑制剂(ICI)治疗生物标志物。
Aging (Albany NY). 2023 Mar 23;15(6):2136-2157. doi: 10.18632/aging.204601.
9
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.LPLUNC1 通过 PHB1-p53/c-Myc 轴减少鼻咽癌细胞中的糖酵解。
Cancer Sci. 2023 Mar;114(3):870-884. doi: 10.1111/cas.15662. Epub 2022 Dec 1.
10
Construction of a lncRNA-mRNA Co-Expression Network for Nasopharyngeal Carcinoma.鼻咽癌长链非编码RNA-信使核糖核酸共表达网络的构建
Front Oncol. 2022 Jul 7;12:809760. doi: 10.3389/fonc.2022.809760. eCollection 2022.
BPIFB1(LPLUNC1)通过与 VTN 和 VIM 相互作用抑制鼻咽癌细胞的迁移和侵袭。
Br J Cancer. 2018 Jan;118(2):233-247. doi: 10.1038/bjc.2017.385. Epub 2017 Nov 9.
4
Mechanisms of DNA-protein crosslink repair.DNA-蛋白质交联修复的机制。
Nat Rev Mol Cell Biol. 2017 Sep;18(9):563-573. doi: 10.1038/nrm.2017.56. Epub 2017 Jun 28.
5
Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.对从原发性鼻咽癌活检标本中分离出的18株爱泼斯坦-巴尔病毒进行全基因组分析。
J Virol. 2017 Aug 10;91(17). doi: 10.1128/JVI.00301-17. Print 2017 Sep 1.
6
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.ATM、ATR 和 DNA-PK:DNA 损伤反应中的三位一体。
Mol Cell. 2017 Jun 15;66(6):801-817. doi: 10.1016/j.molcel.2017.05.015.
7
Molecular Imaging of PARP.聚(ADP - 核糖)聚合酶的分子成像
J Nucl Med. 2017 Jul;58(7):1025-1030. doi: 10.2967/jnumed.117.189936. Epub 2017 May 4.
8
Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.爱泼斯坦-巴尔病毒编码的miR-BART6-3p通过靶向长链非编码RNA LOC553103抑制癌细胞转移和侵袭。
Cell Death Dis. 2016 Sep 1;7(9):e2353. doi: 10.1038/cddis.2016.253.
9
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.EB病毒潜伏膜蛋白1通过DNA-PK/AMPK信号传导抑制DNA损伤反应,从而促进鼻咽癌的放射抗性。
Cancer Lett. 2016 Sep 28;380(1):191-200. doi: 10.1016/j.canlet.2016.05.032. Epub 2016 May 30.
10
RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.RAC1 GTP酶在超分割放射治疗中促进乳腺癌细胞的存活。
Oncogene. 2016 Dec 8;35(49):6319-6329. doi: 10.1038/onc.2016.163. Epub 2016 May 16.